Cargando…

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2

Mostrar otras versiones (2)

Detalles Bibliográficos
Autores principales:	Cui, Shichang, Sun, Yanlei, Liu, Yang, Liu, Chengbiao, Wang, Jinbao, Hao, Guang, Sun, Qidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928685/ https://www.ncbi.nlm.nih.gov/pubmed/29568886 http://dx.doi.org/10.3892/mmr.2018.8785

Ejemplares similares

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2017)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2022)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation
por: Meng, Cuida, et al.
Publicado: (2021)

Corrigendum to “MicroRNA-30-5p Suppresses Inflammatory Factor-Induced Endothelial Cell Injury by Targeting TCF21”
por: Zhou, Zhenyu, et al.
Publicado: (2021)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion
por: Wang, Yu, et al.
Publicado: (2023)

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2016)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

MicroRNA-24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase-1/IL-1β signaling pathway
por: Fan, Zhixing, et al.
Publicado: (2022)

MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
por: Sun, Xin-bo, et al.
Publicado: (2021)

Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression
por: Smith, Amber R., et al.
Publicado: (2015)

microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2
por: Yang, Yanling, et al.
Publicado: (2018)

MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway
por: Wang, Kai, et al.
Publicado: (2021)

MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2
por: Wu, Deyao, et al.
Publicado: (2022)

MicroRNA-137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B
por: Chen, Tengxiang, et al.
Publicado: (2020)

Corrigendum to “Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma”
por: Dong, Shuling, et al.
Publicado: (2017)

[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Publicado: (2019)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

Corrigendum to ‘Databases and Web Tools for Cancer Genomics Study’ [GPB 137 (2015) – GPB 13/1 (46–50)]
por: Yang, Yadong, et al.
Publicado: (2015)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

MirGeneDB 2.0: the metazoan microRNA complement
por: Fromm, Bastian, et al.
Publicado: (2020)

Corrigendum to “Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway” [Redox Biol. 18 (2018) 124–137]
por: Zhao, Xiao-Juan, et al.
Publicado: (2019)

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
por: Iorio, Marilena V, et al.
Publicado: (2017)

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020)

Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis
por: Suzuki, Hiroshi I., et al.
Publicado: (2013)

Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015)

MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1
por: E, Lusha, et al.
Publicado: (2020)

Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis
por: Wang, Zihao, et al.
Publicado: (2021)

Loss of MicroRNA-137 Impairs the Homeostasis of Potassium in Neurons via KCC2
por: Mi, Ting-Wei, et al.
Publicado: (2020)

Long non-coding RNA PITPNA-AS1 silencing suppresses proliferation, metastasis and epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting microRNA-32-5p
por: Chen, Gang, et al.
Publicado: (2021)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemia
por: Jin, Fengyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cu7nsahc982cf33veqatcls0n